Investigation of the Effects of Silymarin on Ovarian Ischemia Reperfusion via Nrf‐2/HO‐1/NQO1, Ki‐67 and Wnt Signaling Pathways
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Ayşe Betül Öztürk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Faculty of Medicine, Aksaray University, Aksaray, Turkey. Hauptthemen laut MEDLINE: Silymarin, Reperfusion Injury, Wnt Signaling Pathway, NF-E2-Related Factor 2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Ovarian ischemia is a pathological condition that usually occurs due to ovarian torsion, resulting in the interruption of blood supply to the ovaries and oxygen deficiency. Silymarin (SLM) is a flavonoid complex of plant origin with pharmacological properties such as antioxidant, anti‐inflammatory, and antiapoptotic effects. In this study, we investigated the effects of SLM through different pathways in rats subjected to experimental ovarian ischemia/reperfusion (I/R). Female Wistar rats were divided into five groups: Control, SLM (50 mg/kg), I/R, I/R + SLM25 (25 mg/kg), and I/R + SLM50 (50 mg/kg). SLM was given orally for 7 days, followed by ischemia (2 h) and reperfusion (2 h) on day 8. Biochemical (MDA, GSH, SOD, CAT, GPx) and histological (H&E, Ki‐67 IHC) analyses were performed. Also, molecular (qRT‐PCR) analyses were performed to evaluate oxidative stress, inflammation, apoptosis, and Wnt signaling. I/R increased MDA and NO levels in ovarian tissue while decreasing SOD, CAT, GPx, and GSH. Antioxidant defense genes (Nrf‐2, HO‐1, NQO1) were suppressed, and inflammation markers (NF‐ĸB, IL‐1β, TNF‐α) along with apoptotic markers (Bax, Caspase‐3) were elevated, while Bcl‐2 decreased. The Wnt signaling pathway was inhibited, particularly at Wnt‐3A, LRP5, Dvl‐2, and Cyclin‐1, reducing Ki‐67 protein levels and IHC positivity. Silymarin has shown a therapeutic effect on ovarian ischemia reperfusion injury with its antioxidant, antiapoptotic and anti‐inflammatory effects and cell cycle regulatory activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
- Department of Histology and Embryology, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
- Department of Physiology, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
Zitieren
APA
Öztürk, A. B., Akaras, N., Şimşek, H., & Kandemir, F. M. (2025). Investigation of the Effects of Silymarin on Ovarian Ischemia Reperfusion via Nrf‐2/HO‐1/NQO1, Ki‐67 and Wnt Signaling Pathways. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70138
Vancouver
Öztürk AB, Akaras N, Şimşek H, Kandemir FM. Investigation of the Effects of Silymarin on Ovarian Ischemia Reperfusion via Nrf‐2/HO‐1/NQO1, Ki‐67 and Wnt Signaling Pathways. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70138
BibTeX
@article{ztrk2025,
author = {Öztürk, Ayşe Betül and Akaras, Nurhan and Şimşek, Hasan and Kandemir, Fatih Mehmet},
title = {Investigation of the Effects of Silymarin on Ovarian Ischemia Reperfusion via Nrf‐2/HO‐1/NQO1, Ki‐67 and Wnt Signaling Pathways},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70138}
}
EUVIMED